Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more
Athens Medical C.S.A. (IATR) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.029x
Based on the latest financial reports, Athens Medical C.S.A. (IATR) has a cash flow conversion efficiency ratio of 0.029x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.17 Million) by net assets (€108.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Athens Medical C.S.A. - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Athens Medical C.S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Athens Medical C.S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CLS HLDGS PLC LS-025
F:838
|
N/A |
|
GENOVIS AB SE-40
F:5GV
|
N/A |
|
All For One Steeb AG
F:A1OS
|
0.009x |
|
Danang Rubber JSC
VN:DRC
|
0.052x |
|
EXCO TECHS LTD
F:3XT
|
N/A |
|
ENB Financial Corp
OTCQX:ENBP
|
0.045x |
|
Optimax Technology Corp
TW:3051
|
0.060x |
|
PDS Limited
NSE:PDSL
|
-0.080x |
Annual Cash Flow Conversion Efficiency for Athens Medical C.S.A. (2014–2024)
The table below shows the annual cash flow conversion efficiency of Athens Medical C.S.A. from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €108.81 Million | €46.44 Million | 0.427x | +77.67% |
| 2023-12-31 | €108.77 Million | €26.13 Million | 0.240x | +19904.30% |
| 2022-12-31 | €103.25 Million | €124.00K | 0.001x | -99.22% |
| 2021-12-31 | €102.06 Million | €15.75 Million | 0.154x | -66.59% |
| 2020-12-31 | €87.07 Million | €40.21 Million | 0.462x | +15.96% |
| 2019-12-31 | €79.08 Million | €31.50 Million | 0.398x | +42.46% |
| 2018-12-31 | €71.62 Million | €20.02 Million | 0.280x | +1258.18% |
| 2017-12-31 | €63.18 Million | €-1.52 Million | -0.024x | -114.98% |
| 2016-12-31 | €60.65 Million | €9.78 Million | 0.161x | -26.39% |
| 2015-12-31 | €58.85 Million | €12.89 Million | 0.219x | +350.93% |
| 2014-12-31 | €73.81 Million | €3.58 Million | 0.049x | -- |